Analyzing Cardiovascular Disease Research in the Arab Region: A Bibliometric Review From 2012 to 2022

Amjad Bani Hani1, Alaa Tarazi2, Yazan Hamadneh2

  • 1General Surgery Department, School of Medicine, The University of Jordan, Amman, Jordan.

Insights

Cardiovascular disease (CVD) research in the Arab region is increasing, with Egypt, Saudi Arabia, and UAE leading. Future studies should focus on heart failure and genetic factors, enhancing regional collaboration.

Area of Science:

  • Bibliometrics
  • Cardiovascular Diseases
  • Middle Eastern Health

Background:

  • Cardiovascular diseases (CVDs) are a primary cause of death globally, particularly in low- and middle-income Arab nations.
  • Assessing scientific output on CVDs in the Arab region and Middle East is crucial for understanding research trends.

Purpose of the Study:

  • To conduct a bibliometric analysis of scientific publications on CVDs in the Arab region and Middle East from 2012 to 2022.
  • To identify key research trends, productive countries, institutions, authors, and journals in CVD research within the specified region.

Main Methods:

  • Bibliometric search performed on PubMed and Scopus databases (2012-2022).
  • Analysis included publication counts, country/institutional/author contributions, journal impact, and keyword frequency.
  • Visualization tools like R, VOSviewer, and CiteSpace were employed for data analysis.

Main Results:

  • 1263 relevant documents were identified after screening from an initial 5340.
  • Annual publications show a consistent increase; Egypt, Saudi Arabia, and UAE are top contributors.
  • Key research areas include heart failure, CVD risk factors, genetic aspects, and congenital cardiac disorders.

Conclusions:

  • The study offers a comprehensive overview of CVD research in the Arab region, highlighting key areas for future investigation.
  • There is a need for expanded research on various CVD aspects in the Arab world.
  • Enhanced collaboration between regional countries and institutions is recommended to advance CVD research.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
280
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Atherosclerosis II: Clinical manifestations and prevention01:27

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
1